Literature DB >> 29386378

Ovarian angiogenesis in polycystic ovary syndrome.

Mariana Di Pietro1, Natalia Pascuali1, Fernanda Parborell1, Dalhia Abramovich2.   

Abstract

Polycystic ovary syndrome (PCOS) is the most prevalent endocrine pathology among women in reproductive age. Its main symptoms are oligo or amenorrhea, hyperandrogenism and the presence of ovarian cysts. It is also associated with infertility, obesity and insulin resistance. Mainly due to its heterogeneity, PCOS treatments are directed to manage its symptoms and to prevent associated diseases. The correct formation and regression of blood vessels during each ovarian cycle is indispensable for proper follicular development, ovulation and corpus luteum formation. The importance of these processes opened a new and promising field: ovarian angiogenesis. Vascular alterations characterize numerous pathologies, either with increased, decreased or abnormal angiogenesis. In the last years, several anomalies of ovarian angiogenesis have been described in women with PCOS. Therefore, it has been suggested that these alterations may be associated with the decreased - or lack of - ovulation rates and for the formation of cysts in the PCOS ovaries. Restoration of a proper vessel formation in the ovaries may lead to improved follicular development and ovulation in these patients. In the present review, we attempt to summarize the alterations in ovarian angiogenesis that have been described in women with PCOS. We also discuss the therapeutic approaches aimed to correct these alterations and their beneficial effects on the treatment of infertility in PCOS.
© 2018 Society for Reproduction and Fertility.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29386378     DOI: 10.1530/REP-17-0597

Source DB:  PubMed          Journal:  Reproduction        ISSN: 1470-1626            Impact factor:   3.906


  14 in total

Review 1.  The ovarian stroma as a new frontier.

Authors:  Hadrian M Kinnear; Claire E Tomaszewski; Faith L Chang; Molly B Moravek; Min Xu; Vasantha Padmanabhan; Ariella Shikanov
Journal:  Reproduction       Date:  2020-09       Impact factor: 3.906

2.  Polymorphisms rs2010963 and rs833061 of the VEGF gene in polycystic ovary syndrome.

Authors:  Anna Luiza Silva Almeida Vicente; Alessandra Bernadete Trovó de Marqui; Mariana Kefalas Oliveira Gomes; Alan Vinicius Assunção-Luiz; Marly Aparecida Spadotto Balarin; Sarah Cristina Sato Vaz Tanaka; Elisabete Aparecida Mantovani Rodrigues de Resende; Marco Fábio Prata Lima; Mariangela Torreglosa Ruiz Cintra
Journal:  Rev Assoc Med Bras (1992)       Date:  2022-06-24       Impact factor: 1.712

3.  Quantitative mass spectrometric analysis to unravel glycoproteomic signature of follicular fluid in women with polycystic ovary syndrome.

Authors:  Krutika Patil; Soujanya Yelamanchi; Manish Kumar; Indira Hinduja; T S Keshava Prasad; Harsha Gowda; Srabani Mukherjee
Journal:  PLoS One       Date:  2019-04-04       Impact factor: 3.240

4.  Effect of Vitamin E on Serum Levels of Vascular Endothelial Growth Factor and Angiopoietin-1 in Women with Polycystic Ovary Syndrome: A Pilot Randomized, Placebo-Controlled Trial.

Authors:  S Habnam Shirazi; Bahram Pourghassem Gargari; Azimeh Izadi; S Hiva Taghizadeh; Marziyeh Parizad
Journal:  Int J Fertil Steril       Date:  2021-01-19

5.  Vascular remodeling by placenta-derived mesenchymal stem cells restores ovarian function in ovariectomized rat model via the VEGF pathway.

Authors:  Jinki Cho; Tae-Hee Kim; Jin Seok; Ji Hye Jun; Hyeri Park; Minyeoung Kweon; Ja-Yun Lim; Gi Jin Kim
Journal:  Lab Invest       Date:  2020-12-10       Impact factor: 5.662

6.  The role of serum β-trophin and endostatin in patients with polycystic ovary syndrome: Are they correlated?

Authors:  Wei Gong; Aikmu Bilixzi; Xinmei Wang; Yanli Lu; Li Wan; Lu Han
Journal:  BMC Womens Health       Date:  2021-03-11       Impact factor: 2.809

7.  Variations in the Profiles of Vascular-Related Factors Among Different Sub-Types of Polycystic Ovarian Syndrome in Northern China.

Authors:  Mei-Mei Liu; Xiu-Hui Chen; Xiu-Min Lu; Fang-Fang Wang; Chao Wang; Yu Liu; Pei-Ling Li; Bo-Tao Du; Sha Liang; Pi-Dong Gong; Yu-Xin Wang
Journal:  Front Endocrinol (Lausanne)       Date:  2021-02-26       Impact factor: 5.555

Review 8.  Heterogeneity and Dynamics of Vasculature in the Endocrine System During Aging and Disease.

Authors:  Sina Stucker; Jessica De Angelis; Anjali P Kusumbe
Journal:  Front Physiol       Date:  2021-03-09       Impact factor: 4.566

9.  Reduced Angiopoietin-2 as a Predictive Biomarker for Clomiphene Citrate Resistance in Polycystic Ovary Syndrome.

Authors:  Luxmipratha Rajendiran; Hanumanthappa Nandeesha; Thyagaraju Chitra
Journal:  J Hum Reprod Sci       Date:  2021-06-28

10.  Methylglyoxal-Dependent Glycative Stress and Deregulation of SIRT1 Functional Network in the Ovary of PCOS Mice.

Authors:  Giovanna Di Emidio; Martina Placidi; Francesco Rea; Giulia Rossi; Stefano Falone; Loredana Cristiano; Stefania Nottola; Anna Maria D'Alessandro; Fernanda Amicarelli; Maria Grazia Palmerini; Carla Tatone
Journal:  Cells       Date:  2020-01-14       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.